Alumni community member
Acorai is redefining heart failure monitoring by developing a non-invasive intracardiac pressure monitor. The hardware with a four-sensor technology combined with a machine learning engine ensures superior signal quality and robustness across patient subtypes and clinical environments.
Filip founded Acorai in 2019 with the vision of transforming the treatment and management of heart failure through novel technology and applied machine learning. He has several years of experience working with Artificial Intelligence within quantitative finance in London and Switzerland and has an MA in Economics from the University of Edinburgh.
Did you know?
50% of heart failure patients require readmission within 6 months, 75% of which may be preventable.